DrugPatentWatch Database Preview
Neurelis Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for NEURELIS INC, and when can generic versions of NEURELIS INC drugs launch?
NEURELIS INC has one approved drug.
There are five US patents protecting NEURELIS INC drugs.
There are forty-eight patent family members on NEURELIS INC drugs in thirteen countries.
Summary for Neurelis Inc
| International Patents: | 48 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Neurelis Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | 10,265,402 | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 8,927,497 | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | 10,265,402 | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | 9,763,876 | Start Trial | Y | Start Trial | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | 8,927,497 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Neurelis Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2011516425 | Start Trial |
| Japan | 2019163273 | Start Trial |
| Canada | 2748268 | Start Trial |
| Japan | 6219272 | Start Trial |
| China | 102325450 | Start Trial |
| European Patent Office | 2720699 | Start Trial |
| European Patent Office | 3082817 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
